Yesterday we saw Integra LifeSciences (IART) fall 4.18% alongside
the market. Both European and emerging-market stocks are facing an especially
dismal start to 2014. Emerging-markets alone have decreased 8.5% this year,
which is the most it has in over twenty years. This puts Integra at risk, being
that approximately 23% of their total revenue is international and 12% of that European. Today the stock bounced back .63%, closing at
a price of $44.80.
No comments:
Post a Comment